510(k) Report

510(k) · Cleared

Cleared

Saige-Dx

K220105510(k) TraditionalCleared May 12, 2022120-day reviewClass II21 CFR 892.2090

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

DeepHealth, Inc. · QDQ Radiological Computer Assisted Detection/Diagnosis Software For Lesions Suspicious For Cancer

Cleared on May 12, 2022 as substantially equivalent to K181704 (Screenpoint Medical B.V., 2018) after a 120-day review. Its family tree reaches back 2 generations to 2018. 4 later devices descend from it.

Decided
May 12, 2022
Review
120 days
Class
Class II
Product code
QDQ
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to DEN180005 (2018). 4 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2024: 2 descendants cleared2025: 1 descendant cleared2026: 1 descendant clearedDEN180005 · OsteoDetect · Imagen Technologies, Inc. · 2018K181704 · Transpara · Screenpoint Medical B.V. · 2018201620182020202220242026
Descendants, by generation 1 generation forward: 1 descendant2 generations forward: 1 descendant3 generations forward: 1 descendant4 generations forward: 1 descendant K181704 · Transpara · Screenpoint Medical B.V. · 2018DEN180005 · OsteoDetect · Imagen Technologies, Inc. · 20180
  1. Root · 2 generations backDEN180005 OsteoDetectImagen Technologies, Inc. · 2018
  2. 1 generation backK181704 TransparaScreenpoint Medical B.V. · 2018
  3. This deviceK220105 Saige-DxDeepHealth, Inc. · 2022
  4. Descendant · cites it directly · 3 of its ownK241747 Saige-DxDeepHealth, Inc. · 2024
  5. Descendant · 2 generations on · 2 of its ownK243688 Saige-Dx (3.1.0)DeepHealth, Inc. · 2024
  6. Descendant · 3 generations on · 1 of its ownK251873 Saige-DxDeepHealth, Inc. · 2025
  7. Descendant · 4 generations on · 0 of its ownK253825 Saige-DxDeepHealth, Inc. · 2026

Most influential descendants

Showing 4 of 4 · See all
  • K241747Saige-DxDeepHealth, Inc. · 2024 · cites it directly3descendants
  • K243688Saige-Dx (3.1.0)DeepHealth, Inc. · 2024 · 2 generations on2descendants
  • K251873Saige-DxDeepHealth, Inc. · 2025 · 3 generations on1descendant
  • K253825Saige-DxDeepHealth, Inc. · 2026 · 4 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2DEN180005OsteoDetectImagen Technologies, Inc.2018—
−1K181704TransparaScreenpoint Medical B.V.2018—
0 (this device)K220105Saige-DxDeepHealth, Inc.2022—
+1K241747Saige-DxDeepHealth, Inc.2024—
+2K243688Saige-Dx (3.1.0)DeepHealth, Inc.2024—
+3K251873Saige-DxDeepHealth, Inc.2025—
+4K253825Saige-DxDeepHealth, Inc.2026—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202420
202510
202610
FIG. 1 — Lineage of K220105, 2018–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QDQ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QDQ device

  1. #1 K241831 Transpara (2.1.0)score 15.6 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K181704Transpara
Summary page 4
…Software Regulation Name and Number: Radiological Computer Assisted Detection and Diagnosis Software (21 CFR 892.2090) Regulation Class: 11 Product Code: QDQ 510(K) No.: K181704 DeepHealth 1000 Massac…
Screenpoint Medical B.V.2018—

Also cleared against K181704: 5 other devices →

What descends from it? (4)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K241747Saige-DxDeepHealth, Inc.20243

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 4 years and passes through 3 companies; a new generation was cleared every 3.5 years on median.
  • None of the 2 ancestors has a recall.
  • Of its descendants, K241747 (DeepHealth, Inc., 2024) has gone furthest, with 3 descendants of its own.
  • 5 other devices also cite its predicate K181704.

How does its category compare?

All QDQ devices

QDQ Radiological Computer Assisted Detection/Diagnosis Software For Lesions Suspicious For Cancer: FDA decisions, review times, recalls and adverse event reports over 20 years. 2022, this device’s year, is highlighted.

FDA decisions per year · QDQ

10so far in 2026, the most since 2007

2018: 22019: 22020: 32021: 52022: 42023: 22024: 72025: 52026 (partial year): 10
2007high 10 (2026) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QDQ

216in 2025

2020: 173 days median2021: 169 days median2022: 131 days median2024: 153 days median2025: 216 days median2026 (partial year): 154 days median
2007high 216 (2025) · low 131 (2022)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · QDQ

No recall names QDQ since 2007.

Adverse event reports per year · QDQ

No MAUDE report names QDQ since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20182—00
20192—00
2020317300
2021516900
2022413100
20232—00
2024715300
2025521600
2026101540—

What is it indicated for?

Saige-Dx analyzes digital breast tomosynthesis (DBT) mammograms to identify the presence or absence of soft tissue lesions and calcifications that may be indicative of cancer. For a given DBT manmogram, Saige-Dx analyzes the DBT image stacks and the accompanying 2D images, including full field digital mammography and/or synthetic images. The system assigns a Suspicion Level, indicating the strength of suspicion that cancer may be present, for each detected finding and for the entire case. The outputs of Saige-Dx are intended to be used as a concurrent reading aid for interpreting physicians on screening mammograms with compatible DBT hardware.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K220105: Saige-Dx.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K220105

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026